Phase II Trial of Continuous Regorafenib Dosing in Patients With Gastrointestinal Stromal Tumors After Failure of Imatinib and Sunitinib

Oncologist - United States
doi 10.1634/theoncologist.2019-0033
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Regorafenib for Advanced Gastrointestinal Stromal Tumors Following Imatinib and Sunitinib Treatment: A Subgroup Analysis Evaluating Japanese Patients in the Phase III GRID Trial

International Journal of Clinical Oncology
MedicineSurgeryOncologyHematology
2015English

Phase II Trial of Imatinib in Metastatic or Unresectable Gastrointestinal Stromal Tumors,NEMROCK Experience.

Research in Oncology
2006English

Comparison of Performance of Various Tumour Response Criteria in Assessment of Regorafenib Activity in Advanced Gastrointestinal Stromal Tumours After Failure of Imatinib and Sunitinib

European Journal of Cancer
Cancer ResearchOncology
2014English

Efficacy and Safety of TAS-116, an Oral Inhibitor of Heat Shock Protein 90, in Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumour Refractory to Imatinib, Sunitinib and Regorafenib: A Phase II, Single-Arm Trial

European Journal of Cancer
Cancer ResearchOncology
2019English

Sunitinib Malate for Gastrointestinal Stromal Tumour in Imatinib Mesylate–resistant Patients: Recommendations and Evidence

Current Oncology
Oncology
2010English

Genetic Polymorphisms as Predictive Biomarker of Survival in Patients With Gastrointestinal Stromal Tumors Treated With Sunitinib

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2017English

Clinical Benefit of Sunitinib in Gastrointestinal Stromal Tumors With Different Exon 11 Mutation Genotypes

Future Oncology
MedicineCancer ResearchOncology
2017English

Optimizing Surgical and Imatinib Therapy for the Treatment of Gastrointestinal Stromal Tumors

Journal of Gastrointestinal Surgery
SurgeryGastroenterology
2013English

Gastrointestinal Stromal Tumors Treated With Imatinib Mesylate: Apparent Diffusion Coefficient in the Evaluation of Therapy Response in Patients

Radiology
Nuclear MedicineRadiologyImaging
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy